143 related articles for article (PubMed ID: 6235230)
1. The level of DNA interstrand crosslinking in bone marrow parallels the extent of myelosuppression in mice treated with four chloroethylnitrosoureas.
Bedford P; Berger MR; Eisenbrand G; Schmähl D
J Cancer Res Clin Oncol; 1984; 108(1):141-7. PubMed ID: 6235230
[TBL] [Abstract][Full Text] [Related]
2. Relationship between DNA damage and the inhibition of stem cells in murine bone marrow after single and repeated administration of BCNU and HECNU.
Berger MR; Henne T; Bedford P
J Cancer Res Clin Oncol; 1985; 110(3):185-90. PubMed ID: 4077917
[TBL] [Abstract][Full Text] [Related]
3. DNA damage and repair in the bone marrow of rats treated with four chloroethylnitrosoureas.
Bedford P; Eisenbrand G
Cancer Res; 1984 Feb; 44(2):514-8. PubMed ID: 6229329
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of human and murine hematopoietic precursor cells to 2-[3-(2-chloroethyl)-3-nitrosoureido]-D-glucopyranose and 1,3-bis(2-chloroethyl)-1-nitrosourea.
Schein PS; Bull JM; Doukas D; Hoth D
Cancer Res; 1978 Feb; 38(2):257-60. PubMed ID: 620400
[TBL] [Abstract][Full Text] [Related]
5. Chemical structure of carbamoylating groups and their relationship to bone marrow toxicity and antiglioma activity of bifunctionally alkylating and carbamoylating nitrosoureas.
Ali-Osman F; Giblin J; Berger M; Murphy MJ; Rosenblum ML
Cancer Res; 1985 Sep; 45(9):4185-91. PubMed ID: 2411398
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of chlorozotocin and BCNU on hematopoietic precursor cells.
Horikoshi A; Smith R; Murphy MJ
Chemotherapy; 1983; 29(2):135-44. PubMed ID: 6220871
[TBL] [Abstract][Full Text] [Related]
7. An analysis of 1-(2-chloroethyl)-1-nitrosourea activity at the cellular level.
Weinkam RJ; Dolan ME
J Med Chem; 1983 Nov; 26(11):1656-9. PubMed ID: 6226795
[TBL] [Abstract][Full Text] [Related]
8. Biological and biochemical properties of 1-(2-chloroethyl)-3-(beta-D-glucopyranosyl)-1-nitrosourea (NSC D 254157), a nitrosourea with reduced bone marrow toxicity.
Fox PA; Panasci LC; Schein PS
Cancer Res; 1977 Mar; 37(3):783-7. PubMed ID: 138478
[TBL] [Abstract][Full Text] [Related]
9. Chlorozotocin. Mechanism of reduced bone marrow toxicity in mice.
Panasci LC; Green D; Schein PS
J Clin Invest; 1979 Oct; 64(4):1103-11. PubMed ID: 158033
[TBL] [Abstract][Full Text] [Related]
10. Comparative studies on the antitumor activity and the bone marrow toxicity of 1-(beta-D-glucopyranosyl)-3-(2-chloroethyl)-3-nitrosourea and 2-(3-(2-chloroethyl)-3-nitrosoureido)-D-glucopyranose.
Aoshima M; Sakurai Y
Gan; 1977 Apr; 68(2):247-50. PubMed ID: 892299
[TBL] [Abstract][Full Text] [Related]
11. Chlorozotocin, 2-(3-(2-chloroethyl)-3-nitrosoureido)-D-glucopyranose, an antitumor agent with modified bone marrow toxicity.
Anderson T; McMenamin MG; Schein PS
Cancer Res; 1975 Mar; 35(3):761-5. PubMed ID: 123170
[TBL] [Abstract][Full Text] [Related]
12. Specific DNA repair mechanisms may protect some human tumor cells from DNA interstrand crosslinking by chloroethylnitrosoureas but not from crosslinking by other anti-tumor alkylating agents.
Gibson NW; Zlotogorski C; Erickson LC
Carcinogenesis; 1985 Mar; 6(3):445-50. PubMed ID: 3978757
[TBL] [Abstract][Full Text] [Related]
13. Nitrosourea-misonidazole combination chemotherapy: effect on KHT sarcomas, marrow stem cells and gut.
Mulcahy RT; Siemann DW; Sutherland RM
Br J Cancer; 1982 Jun; 45(6):835-42. PubMed ID: 6212075
[TBL] [Abstract][Full Text] [Related]
14. Effect of cell cycle position on the survival of 9L cells treated with nitrosoureas that alkylate, cross-link, and carbamoylate.
Linfoot PA; Gray JW; Dean PN; Marton LJ; Deen DF
Cancer Res; 1986 May; 46(5):2402-6. PubMed ID: 3697983
[TBL] [Abstract][Full Text] [Related]
15. Reversal of 1,3-bis(2-chloroethyl)-1-nitrosourea-induced severe immunodeficiency by transduction of murine long-lived hemopoietic progenitor cells using O6-methylguanine DNA methyltransferase complementary DNA.
Maze R; Kapur R; Kelley MR; Hansen WK; Oh SY; Williams DA
J Immunol; 1997 Jan; 158(2):1006-13. PubMed ID: 8993023
[TBL] [Abstract][Full Text] [Related]
16. Examination of four newly synthesized 2-chloroethylnitrosoureas in comparison with BCNU, CCNU, MeCCNU, chlorozotocin and hydroxyethyl-CNU in preterminal rat leukemia L 5222.
Zeller WJ; Eisenbrand G; Fiebig HH
J Cancer Res Clin Oncol; 1979 Sep; 95(1):43-9. PubMed ID: 159309
[TBL] [Abstract][Full Text] [Related]
17. Repair of DNA alkylation induced in L1210 leukemia and murine bone marrow by three chloroethylnitrosoureas.
Ahlgren JD; Green DC; Tew KD; Schein PS
Cancer Res; 1982 Jul; 42(7):2605-8. PubMed ID: 6211225
[TBL] [Abstract][Full Text] [Related]
18. Comparison of DNA damage in various tissues, myelosuppression and serum levels of transaminases and bilirubin in tumor-bearing female Sprague-Dawley rats treated with 1-(2-hydroxyethyl)-3-(2-chloroethyl)-3-nitrosourea (HECNU).
Henne T; Berger MR
J Cancer Res Clin Oncol; 1986; 111(1):75-8. PubMed ID: 3949853
[TBL] [Abstract][Full Text] [Related]
19. Anticancer nitrosoureas: investigations on antineoplastic, toxic and neoplastic activities.
Eisenbrand G
IARC Sci Publ; 1984; (57):695-708. PubMed ID: 6533062
[TBL] [Abstract][Full Text] [Related]
20. Retrovirus-mediated expression of a DNA repair protein in bone marrow protects hematopoietic cells from nitrosourea-induced toxicity in vitro and in vivo.
Moritz T; Mackay W; Glassner BJ; Williams DA; Samson L
Cancer Res; 1995 Jun; 55(12):2608-14. PubMed ID: 7780976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
